Prosztatarák: vizsgálatok itt: Olaszország
119 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
- Where
- Many Locations
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Bayer
See details and how to joinNCT07344779 - 3. fázisNot yet taking people in OlaszországAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Where
- Milan, Misterbianco, Naples, Negrar, Reggio Emilia, Rozzano
- Életkor
- 18 év and over
- People
- 670 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07611110 - No phaseTaking peoplePSMA-Guided Surgery and Tissue-Resident T-Cell Profiling in Node-Positive Prostate Cancer
- Where
- Milan
- Életkor
- 18 év to 85 év
- People
- 12
- Run by
- Niguarda Hospital
See details and how to joinNCT07879820 - 3. fázisTaking peopleA Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
- Where
- Candiolo, Foggia, Genoa, Lecce, Meldola, Milan, Pisa, Rozzano, Verona
- Életkor
- 18 év and over
- People
- 736 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07365995 · EU 2025-524445-27-00 - 1/2. fázisTaking peopleA Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
- Where
- Cona, Milan, Naples
- Életkor
- 18 év and over
- People
- 123 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07226986 · EU 2025-521859-23-00 - 3. fázisNot yet taking people in OlaszországSaruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
- Where
- Bari, Genoa, Padova, Rozzano
- Életkor
- 18 év and over
- People
- 1330 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07711002 · EU 2026-526275-38-00 - No phaseNot yet taking people in OlaszországArtificial Intelligence Software (Prostate Intelligence) for Detecting Clinically Significant Prostate Cancer on MRI
- Where
- Rome
- Életkor
- 18 év and over
- People
- 226
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07875491 - 3. fázisTaking peopleA Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Where
- Arezzo, Bari, Bergamo, Chieti, Genoa, Milan, Naples, Palermo, Pisa, Rome, Rozzano, Turin, Varese, Verona
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06952803 · EU 2024-513586-39-00 - 3. fázisFut, nem toborozThis Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Where
- Bologna, Meldola, Milan, Novara, Orbassano, Padova, Ravenna, Rome, Rozzano, Trento, Verona
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Pfizer
See details and how to joinNCT07028853 · EU 2024-519369-24-00 - 1/2. fázisNot yet taking people in OlaszországPhase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Where
- Bergamo, Meldola, Milan, Roma
- Életkor
- 18 év to 99 év
- People
- 152 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07590934 - 1/2. fázisFut, nem toborozA Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- Where
- Brescia, Milan, Naples, Orbassano, Rome
- Életkor
- 18 év and over
- People
- 360 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06863272 · EU 2024-516036-94-00 - 1/2. fázisTaking peopleAn Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
- Where
- Milan, Orbassano, Padova
- Életkor
- 18 év and over
- People
- 188 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07206056 · EU 2025-521880-10-00 - 1/2. fázisTaking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Candiolo, Milan, Naples, Rome, Rozzano
- Életkor
- 12 év and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Ancona, Bologna, Florence, Milan, Naples, Ravenna
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - 2. fázisTaking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Milan, Naples
- Életkor
- 18 év to 130 év
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - 1. fázisNot yet taking people in OlaszországPhase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Where
- Milan, Naples
- Életkor
- 18 év to 100 év
- People
- 116 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00 - 1. fázisTaking peopleEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Where
- Candiolo, Rozzano
- Életkor
- 18 év and over
- People
- 540 worldwide
- Run by
- SystImmune Inc.
See details and how to joinNCT05983432 - 3. fázisTaking peoplePhase 3 Study of Xaluritamig Plus Abiraterone vs Investigator's Choice in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Where
- Foggia, Milan, Modena, Orbassano, Peschiera del Garda, Rozzano, Trento
- Életkor
- 18 év and over
- People
- 297 worldwide
- Run by
- Amgen Inc.
See details and how to join2025-520555-89-00 - 1. fázisNot yet taking people in OlaszországClinical study to evaluate the safety and efficacy of a new targeted radioactive drug treatment for advanced prostate cancer
- Where
- Milan
- Életkor
- 18 év and over
- People
- 5
- Run by
- Fondazione IRCCS Istituto Nazionale Dei Tumori
See details and how to join2026-525244-14-00 - No phaseTaking peopleImplementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration
- Where
- Milan
- Életkor
- 18 év and over
- People
- 125
- Run by
- European Institute of Oncology
See details and how to joinNCT06762379 - 3. fázisNot yet taking people in Olaszország64CuCl2 PET/CT VS 18F-choline PET/CT in prostate cancer
- Where
- Genoa, Rome
- Életkor
- 18 év and over
- People
- 285
- Run by
- A.C.O.M. Advanced Center Oncology Macerata S.r.l.
See details and how to join2025-520861-29-00 - 2. fázisTaking peopleFully hybrid 18F-PSMA PET/MRI as one-stop approach for the diagnosis of clinically significant prostate cancer
- Where
- Milan
- Életkor
- 18 év and over
- People
- 167
- Run by
- Ospedale San Raffaele S.r.l.
See details and how to join2024-512859-21-00 - 3. fázisTaking people[18F]PSMA-1007 PET CT in patients with newly-diagnosed prostate cancer
- Where
- Meldola, Negrar
- Életkor
- 18 év and over
- People
- 355 worldwide
- Run by
- Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GmbH
See details and how to join2023-504026-19-01 - 2. fázisBefejeződöttA Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- Where
- Milan, Modena, Naples, Rome, Rozzano, Trento
- Életkor
- 18 év and over
- People
- 218 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07005154 · EU 2024-517653-27-00 - 1/2. fázisNot yet taking people in OlaszországA Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
- Where
- Rome, Rozzano
- Életkor
- 18 év and over
- People
- 52 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07192614 · EU 2025-520626-37-00